ROR1 and ovarian carcinoma: Overexpression of tyrosine kinase-like orphan receptor 1 (ROR1) has been documented in B-CLL, mantle cell lymphoma (MCL), breast cancer, B-ALL, lung adenocarcinoma, melanoma and ovarian cancer [21–30].